Turn this list into an evaluation

Each entry is an FDA submission, not a distinct commercial offer. Inspect the exact record before comparing evidence, asking for a quote or planning an integration.

Prepare with a buyer guide:

Clinical guide links appear when this list contains a current reviewed example. They do not classify or endorse the other entries. All buyer guides · Compare exact records · Documented families

FDA-approved P130020/S005

Senographe Pristina 3D

GE Healthcare

PMA supplement updates digital breast tomosynthesis reconstruction with deep learning to correct sparse-view artifacts, compensate patient motion, and enhance soft-tissue lesion visibility in the synthetic 2D image.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2025-11-21
FDA-cleared K242925

MR Contour DL

GE HealthCare

Authorized purpose: MR Contour DL generates DICOM RT Structure Sets with initial organ-at-risk contours from adult MR images to accelerate radiation-treatment planning; users must verify, correct, and approve contours and labels.

Modality
Radiotherapy Planning Imaging
Anatomy
Adult anatomy represented by organs at risk on MR images
Decision
2025-04-01
FDA-cleared K223212

Precision DL

GE Healthcare

Precision DL uses deep-learning image processing to enhance non-time-of-flight F-18 FDG PET images for clinical oncology review in adults and children.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2023-04-27
FDA-cleared K221680

Xeleris V Processing and Review System

GE Healthcare

Authorized purpose: The Xeleris V Processing and Review System displays, processes, archives, prints, reports, and networks planar, SPECT, and PET nuclear-medicine data, with optional applications for DaTQUANT, lung analysis, brain analysis, coronary-flow reserve, prostate-cancer bone metastases, liver shunt and dose calculations, and monitoring of patient radiation doses from nuclear-medicine imaging data.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body, lung, brain, liver, cardiac, coronary, and other anatomy represented in labeled nuclear-medicine studies
Decision
2023-03-01
FDA-cleared K213689

Voluson P6, Voluson P8

GE Healthcare

Authorized purpose: Voluson P6 and Voluson P8 are general-purpose diagnostic ultrasound systems for qualified healthcare professionals across the labeled fetal, obstetric, abdominal, gynecologic, pediatric, small-organ, cephalic, cardiac, vascular, musculoskeletal, urologic, and transvaginal applications.

Modality
Ultrasound
Anatomy
Fetus; abdomen; pelvis; small organs; head; heart; peripheral vessels; musculoskeletal; and urologic anatomy
Decision
2022-02-17
FDA-cleared K213642

Voluson S6, Voluson S8, Voluson S8t, Voluson S10, Voluson S10 Expert

GE Healthcare

Authorized purpose: Voluson S6, S8, S8t, S10, and S10 Expert are general-purpose diagnostic ultrasound systems for qualified healthcare professionals across the labeled fetal, obstetric, abdominal, gynecologic, pediatric, small-organ, cephalic, cardiac, vascular, musculoskeletal, and urologic applications.

Modality
Ultrasound
Anatomy
Fetus; abdomen; pelvis; small organs; head; heart; peripheral vessels; musculoskeletal; and urologic anatomy
Decision
2022-01-13
FDA-cleared K201103

Xeleris V Processing and Review Systems

GE Healthcare

Authorized purpose: Xeleris V is intended for nuclear-medicine or radiology practitioners and referring physicians to display, process, archive, print, report, and network nuclear-medicine data from gamma cameras or PET scanners. PET or nuclear-medicine data may be registered or fused with CT or MR and physiologic signals to depict, localize, or quantify radionuclide tracers and anatomical structures. The labeled applications include DaTQUANT review of 123I-ioflupane images, Q.Lung support for pulmonary embolism, COPD, emphysema, lung-function assessment, and resection planning, and Q.Brain review of brain metabolic function or blood flow in specified neurologic conditions.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole-body, lung, brain/striatum, and other anatomy represented in nuclear-medicine, PET, CT, and MR studies
Decision
2020-09-25